ACA
QTTB icon

Acorn Capital Advisors’s Q32 Bio QTTB Stock Holding History

Acorn Capital Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Sell
315,052
-178,373
-36% -$847K 0.57% 17
2025
Q4 		$1.64M Sell
493,425
-310,000
-39% -$876K 0.56% 18
2025
Q3 		$1.59M Hold
803,425
– – 0.81% 17
2025
Q2 		$1.2M Hold
803,425
– – 0.78% 19
2025
Q1 		$1.33M Hold
803,425
– – 0.88% 20
2024
Q4 		$2.76M Buy
+803,425
New +$25.4M 1.49% 17

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Acorn Capital Advisors's QTTB Position: Q1 2026 in Review

Acorn Capital Advisors reduced its Q32 Bio (QTTB) stake by 36% in Q1 2026, selling an estimated $847K and leaving 315,052 shares worth $2.02M. The position accounts for 0.57% of the portfolio, ranked #17.

Acorn Capital Advisors first reported a position in QTTB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.76M in Q4 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Acorn Capital Advisors held 315,052 shares of Q32 Bio worth $2.02M as of Q1 2026.
  • Acorn Capital Advisors sold 178,373 Q32 Bio shares in Q1 2026, an estimated $847K.
  • Q32 Bio made up 0.57% of Acorn Capital Advisors's portfolio in Q1 2026, its #17 holding.
  • Acorn Capital Advisors first reported a position in Q32 Bio in Q4 2024 and has held it in 6 quarters since.
  • Acorn Capital Advisors's Q32 Bio position peaked at $2.76M in Q4 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Acorn Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.